(Bloomberg) — Shares of NovaBay Pharmaceuticals Inc., which sold for a record-low 23 cents in mid-May, rallied to more than $3 on Monday after the company said it would sell its eye drug without a …

More NovaBay Loses Penny Stock Stigma After Taking Eye Drug Online Videos